Daclatasvir Dihydrochloride and Rabeprazole Delayed-Release Tablets
Determining the interaction of Daclatasvir Dihydrochloride and Rabeprazole Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: rabeprazole
Brand name: Aciphex, AcipHex Sprinkle
Synonyms: Rabeprazole, RABEprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Rabeprazole Sodium
- Daclatasvir Dihydrochloride-Rabeprazole Sprinkle Capsules
- Daclatasvir Dihydrochloride-Rabies Immune Globulin
- Daclatasvir Dihydrochloride-Rabies immune globulin human
- Daclatasvir Dihydrochloride-Rabies immune globulin Intramuscular
- Daclatasvir Dihydrochloride-Rabies Vaccine
- Rabeprazole Delayed-Release Tablets-Daclizumab
- Rabeprazole Delayed-Release Tablets-Daclizumab Subcutaneous
- Rabeprazole Delayed-Release Tablets-Dacogen
- Rabeprazole Delayed-Release Tablets-Dacomitinib
- Rabeprazole Delayed-Release Tablets-Dactinomycin
- Rabeprazole Delayed-Release Tablets-Dactinomycin Injection